Skip to main content
Clinical Trials/KCT0008818
KCT0008818Not yet recruitingUnknown

Single center, randomized, prospective, comparative study to evaluate the efficacy and safety of Megaderm® Star” in breast reconstruction with implants after mastectomy in breast cancer patients

Asan Medical Center0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20(Year) to 79(Year) (—)
Sex
All

Inclusion Criteria

  • ? Patients who signed the subject description and consent form
  • ? Patients between the ages of 20 and 79
  • ? For breast cancer treatment, patients who are scheduled to perform radial incision during mastectomy
  • ? Patients who are scheduled to undergo Prepectoral direct-to-implant breast reconstruction by applying ADM (MegaDerm® STAR” or MegaDerm® Flex HD”)

Exclusion Criteria

  • ? Patients who have previously undergone mastectomy, breast augmentation, or breast reconstruction
  • ? In case both breasts are performed at the same time or in case of reduction of the opposite side
  • ? In case of inserting an expander
  • ? Patients who have undergone organ transplantation and are taking immunosuppressants
  • ? Patients whose mental state may affect the progress of the clinical trial due to alcohol or drug abuse
  • ? Patients who are unable to proceed with the survey conducted in this clinical trial
  • ? Patients who find it difficult to conduct this clinical trial at the discretion of the researcher

Investigators

Similar Trials